Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teekay

6.69
-0.2700-3.88%
Post-market: 6.690.00000.00%17:17 EDT
Volume:1.91M
Turnover:12.89M
Market Cap:562.36M
PE:4.71
High:6.92
Open:6.91
Low:6.67
Close:6.96
Loading ...

Teekay Group to Announce Fourth Quarter and Annual 2024 Earnings Results on February 19, 2025

GlobeNewswire
·
12 Feb

Prabowo Vows All Children Will Receive Free Nutritious Meals by Year's End

Tempo
·
21 Jan

TK Group Expects 20% Profit Growth in 2024

MT Newswires Live
·
17 Jan

Himax Technologies And 2 Other Undiscovered Gems In The United States

Simply Wall St.
·
16 Jan

Earnings Working Against Teekay Corporation Ltd.'s (NYSE:TK) Share Price

Simply Wall St.
·
14 Jan

Teekay (NYSE:TK) Shareholders Will Want The ROCE Trajectory To Continue

Simply Wall St.
·
14 Jan

TK Group Signs Leasing Framework Agreement with TK Technology

TIPRANKS
·
23 Dec 2024

Discovering Undiscovered Gems in the US This December 2024

Simply Wall St.
·
18 Dec 2024

Teekay Corporation Ltd. (NYSE:TK) is largely controlled by institutional shareholders who own 81% of the company

Simply Wall St.
·
13 Dec 2024

Teekay Announces Strategic Board Restructuring

TIPRANKS
·
10 Dec 2024

BRIEF-Teekay Group Announces Changes To Boards Of Directors

Reuters
·
10 Dec 2024

Teekay Corp : the Teekay Board Has Appointed Current Director, Heidi Locke Simon, to Take Over as Chair of Teekay Board

THOMSON REUTERS
·
10 Dec 2024

Teekay Corp : David Schellenberg, Alan Semple to Step Down as Board Directors, as Board Chair & Audit Committee Chair, Respectively

THOMSON REUTERS
·
10 Dec 2024

Teekay Group Announces Changes to Boards of Directors

THOMSON REUTERS
·
10 Dec 2024

Teekay Group Announces Changes to Boards of Directors

GlobeNewswire
·
10 Dec 2024

Lantern Pharma Announces First Patient Enrolled in Taiwan for Phase 2 HARMONIC™ Clinical Trial of LP-300 in Never-Smoker NSCLC Patients

Business Wire
·
09 Dec 2024